More Kids Without Asthma Inhaler After Flovent Taken Off Market

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on April 30, 2025.

By Dennis Thompson HealthDay Reporter

WEDNESDAY, April 30, 2025 — More children stopped using steroid inhalers to control their asthma after a manufacturer discontinued a popular inhaler, a new study says.

In 2024, GlaxoSmithKline withdrew Flovent from the market. The inhaler was commonly prescribed to prevent asthma attacks in children.

The pharma company continued to sell a chemically identical “authorized generic,” but some families reportedly had trouble getting this drug because their insurance either didn’t cover it or required higher out-of-pocket costs, researchers reported April 26 in the Journal of the American Medical Association.

As a result, children were 6 percentage points more likely to have no steroid inhaler in hand to prevent an asthma attack, results show.

Asthma inhaler access dropped from nearly 41% to nearly 35% between 2021 and 2023 among patients 18 and younger prescribed Flovent (fluticasone), researchers found.

By comparison, young asthma patients prescribed other inhaled steroids had about the same access to an inhaler, at a consistent level around 38%, results show.

“Our findings suggest the withdrawal of Flovent disrupted inhaled steroid therapy in children, potentially increasing their risk of asthma attacks,” lead researcher Dr. Kao-Ping Chua, a pediatrician at the University of Michigan Health C.S. Mott Children's Hospital, said in a news release.

Researchers said Flovent was likely pulled from the market due to changes in rebates that manufacturers must pay to Medicaid programs to obtain drug coverage.

Historically, these rebates were capped, but the American Rescue Plan Act of 2021 eliminated this cap in January 2024, researchers said.

Eliminating the cap would have resulted in rebates that exceeded Flovent’s sales price because GSK had previously increased the drug’s price rapidly, researchers said. That exposed them to a rebate that applies when increases in a drug’s price outpaces inflation.

“Our findings suggest that the elimination of the Medicaid rebate cap had unintended consequences for children with asthma,” Chua said.

He noted that other drugs also have triggered the rebate cap, including meds for diabetes and infections.

“If other brand name drugs are withdrawn due to elimination of the rebate cap, policymakers should proactively implement interventions to prevent therapy disruptions, such as ensuring insurer coverage of alternative drugs,” Chua said.

Sources

  • University of Michigan, news release, April 26, 2025

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2025-05-01 06:00

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords